Combined ivermectin and intense pulsed light therapy can help resolve Demodex blepharitis and prevent its recurrence.

Tarsus Pharmaceuticals' lotilaner shows strong market performance for Demodex blepharitis, but cautious investment due to ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $60.0, a high ...